Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention. [electronic resource]
Producer: 20161215Description: e1275-82 p. digitalISSN:- 1969-6213
- Abciximab
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Anticoagulants -- therapeutic use
- Antithrombins -- therapeutic use
- Female
- Heparin -- therapeutic use
- Hirudins
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Peptide Fragments -- therapeutic use
- Percutaneous Coronary Intervention -- methods
- Platelet Aggregation Inhibitors -- therapeutic use
- Recombinant Proteins -- therapeutic use
- Risk
- Stents
- Thrombosis -- mortality
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.